Filing Analysis
Sintx Technologies entered into a letter agreement with MedTech Ceramics, LP to restructure existing equity holdings and warrants. This involves the issuance of 255,267 shares from abeyance and the replacement of old warrants with new instruments totaling over 1.2 million potential shares.
🚩 Red Flags
- Significant dilution: The new warrant alone covers 1,268,135 shares, which is substantial for a micro-cap company.
- Full-ratchet anti-dilution: The New Warrant contains a full-ratchet downward adjustment provision, which is highly dilutive to existing shareholders in future financing rounds.
- Pre-funded warrant: The Pre-Funded Warrant has no fixed expiration date and requires no additional cash upon exercise, representing 'dead weight' on the cap table.
- Complex equity restructuring involving a single holder (MedTech Ceramics, LP) suggests intensive management of capital structure to satisfy specific creditors/investors.
📋 Key Facts
- Effective date: June 29, 2026.
- Issuance of 255,267 shares of Common Stock from abeyance to MedTech Ceramics, LP for no additional consideration.
- Replacement of 251,987 abeyance shares with a Pre-Funded Warrant (no expiration date).
- Replacement of an existing warrant (760,881 shares) with a New Warrant for 1,268,135 shares at $2.14 per share.
- The New Warrant expires in five years and includes a full-ratchet downward adjustment provision for dilutive financing.
- Company committed to filing a resale registration statement within 45 days.
SINTX Technologies, Inc. entered into a private placement agreement on June 2, 2026, to sell 1,882,845 units at $2.39 per unit, raising approximately $4.5 million in gross proceeds. Each unit consists of one share of common stock and two separate warrants (Class A and Class B).
🚩 Red Flags
- Significant dilution: The offering includes 200% warrant coverage, meaning up to 3.76 million additional shares could be issued via warrants in addition to the 1.88 million shares sold.
- Potential for 'death spiral' characteristics: Both warrant classes include anti-dilution adjustments if the company issues stock at a lower price in the future.
📋 Key Facts
- Gross proceeds of approximately $4.5 million from the sale of 1,882,845 units.
- Unit price set at $2.39 per unit.
- Warrant coverage is 200%: each unit includes one Class A Warrant (5-year term) and one Class B Warrant (2-year term).
- Both Class A and Class B warrants have an exercise price of $2.14 per share.
- Company engaged Partner Capital Group, LLC as a consultant with a 7% cash placement fee.
- Company committed to filing a resale registration statement within 30 days of closing.
SINTX Technologies received a notice from Nasdaq on May 22, 2026, stating it is not in compliance with Listing Rule 5550(b)(1) due to stockholders' equity falling below the required $2.5 million minimum.
🚩 Red Flags
- Stockholders' equity is significantly below the required minimum ($904k vs $2.5M).
📋 Key Facts
- Nasdaq Listing Rule 5550(b)(1) requires a minimum of $2.5 million in stockholders' equity.
- As of March 31, 2026, the Company reported stockholders' equity of approximately $904,000.
- The Company does not meet alternative listing standards (market value of listed securities >= $35M, or net income >= $500k in most recent fiscal year or 2 of last 3 years).
- The Company has until July 6, 2026, to submit a plan to regain compliance.
- If a plan is accepted, an extension of up to 180 days may be granted.
SINTX Technologies, Inc. announced a leadership transition where Eric Olson will step down as President to focus on his roles as CEO and Chairman, effective March 16, 2026. Ryan Elmore has been appointed as the new President, bringing over 20 years of medical device industry experience.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- Eric Olson to cease serving as President effective March 16, 2026; will remain CEO and Chairman of the Board.
- Ryan Elmore appointed President, effective March 16, 2026.
- Elmore's compensation includes a $375,000 base salary and a guaranteed first-year annual bonus (target 35% of base).
- A $100,000 sign-on bonus is payable upon commencement, subject to a 12-month clawback provision.
- Equity includes an RSU award with a grant date value of $300,000 (20% vesting immediately, remainder over 24 months).
- Severance package for Elmore includes 2x base salary plus target bonus and 24 months of health benefits if terminated without cause.
SINTX Technologies, Inc. has entered into a supply agreement with Evonik Corporation to manufacture its proprietary silicon nitride–PEEK compound (SiN/PEEK). The announcement was made via press release on December 1, 2025.
📋 Key Facts
- Company signed a supply agreement with Evonik Corporation.
- The agreement concerns the manufacturing of SINTX's proprietary silicon nitride–PEEK compound (SiN/PEEK).
- Filing date: December 1, 2025.
SINTX Technologies, Inc. filed an 8-K to announce its quarterly financial results for the period ended September 30, 2025. The filing serves as a formal notice that a press release containing non-GAAP financial measures has been issued.
📋 Key Facts
- The company announced financial results for the quarter ended September 30, 2025.
- A press release (Exhibit 99.1) was issued on November 13, 2025.
- The filing includes information regarding the Company's use of non-GAAP financial measures.
SINTX Technologies, Inc. entered into an At The Market (ATM) offering agreement with H.C. Wainwright & Co., LLC to sell common stock from time to time. The filing includes a prospectus supplement for an aggregate offering price of approximately $6.41 million.
🚩 Red Flags
- Potential dilution for existing shareholders through the issuance of new common stock.
- ATM offerings are often used by micro-cap companies to raise immediate working capital, which can signal liquidity needs.
📋 Key Facts
- Entered into ATM Agreement with H.C. Wainwright & Co., LLC on October 3, 2025.
- Aggregate offering price specified in the prospectus supplement is $6,413,876.
- Wainwright will receive a commission rate of 3.0% of aggregate gross sales.
- Shares to be issued under an existing shelf registration statement (Form S-3) effective November 27, 2023.
- The company is not obligated to sell any shares and may suspend the program at any time.
Sintx Technologies entered into an inducement agreement with existing warrant holders to induce the exercise of 1,099,431 warrants at $3.32 per share in exchange for issuing new warrants totaling 1,649,147 shares at $4.79 per share. The transaction is expected to generate approximately $3.8 million in gross proceeds and will result in significant dilution of existing shareholders.
🚩 Red Flags
- Significant Dilution: Total shares outstanding increasing by approximately 38.6%.
- Warrant Overhang: Issuance of a large number of new warrants (1.6M+) creates significant future dilution.
- Cash-for-Warrants Structure: The company is essentially paying holders to exercise old warrants by giving them even more warrants at a higher price, suggesting difficulty in raising capital through traditional means.
📋 Key Facts
- Existing Warrants: 1,099,431 shares at an exercise price of $3.32/share.
- New Warrants: Up to 1,649,147 shares at an exercise price of $4.79/share.
- Expected gross proceeds from existing warrant exercise: ~$3.8 million.
- Placement Agent (H.C. Wainwright & Co., LLC) fees include a 7.5% cash fee and a 1.0% management fee.
- The transaction will increase total shares outstanding from 2,850,957 to 3,950,388 (a ~38.6% increase).
- New warrants are immediately exercisable for 5.5 years.
SINTX Technologies, Inc. announced the appointment of Kevin Trask as Chief Financial Officer on September 4, 2025. The filing also details results from the company's 2025 Annual Meeting of Stockholders, including the election of directors and approval of a new equity incentive plan.
🚩 Red Flags
- Rapid turnover in finance leadership: Mr. Trask moved from Corporate Controller to CFO within a 4-month window (May 2025 to September 2025).
📋 Key Facts
- Kevin Trask appointed as CFO; previously served as Corporate Controller since May 2025.
- CFO compensation includes $300,000 annual salary and up to 35% discretionary bonus.
- Award of 20,000 RSUs granted to Mr. Trask (20% immediately vested).
- Stockholders approved the 2025 Equity Incentive Plan.
- Tanner LLC was ratified as the independent registered public accounting firm for fiscal year ending Dec 31, 2025.
- Robert Mitchell and Chris Lyons were elected to the Board of Directors for three-year terms.
SINTX Technologies, Inc. announced the submission of an FDA 510(k) application for its Silicon Nitride Foot & Ankle Medical Devices on July 22, 2025.
📋 Key Facts
- Company submitted an FDA 510(k) application for Silicon Nitride Foot & Ankle Medical Devices.
- Submission date: July 22, 2025.
- The filing is under Item 7.01 (Regulation FD Disclosure), meaning the information is furnished but not 'filed' for liability purposes.
SINTX Technologies entered into an Asset Purchase Agreement to acquire substantially all assets of Sinaptic Surgical, LLC. The deal includes the issuance of milestone-based warrants and a private placement of common stock.
🚩 Red Flags
- Significant dilution potential through milestone-based warrants and a private placement of shares.
- The company is obligated to file a resale registration statement for the purchased shares and warrant shares within 90 days of closing.
📋 Key Facts
- Acquisition of substantially all assets and assumption of certain liabilities of Sinaptic Surgical, LLC.
- Company to issue 325,000 warrants with an exercise price of $6.30 per share.
- Warrants vest based on milestones: 510k FDA clearance for a foot/ankle implant and revenue targets ($2.5M, $5M, $10M, and $15M).
- Sinaptic Surgical to purchase 216,450 shares of common stock at $3.465 per share in a private placement.
- A 5% royalty on net revenue from certain implants is due if $15 million in revenue is achieved by the 4th anniversary.
- Expected closing date: July 1, 2025.
SINTX Technologies, Inc. issued a press release regarding the issuance of a new patent and the formation of a subsidiary aimed at antimicrobial applications within the agribiotech market.
📋 Key Facts
- Date of report: May 22, 2025
- Company announced the issuance of a new patent.
- Company formed a new subsidiary to focus on agribiotech antimicrobial applications.
- The disclosure was made under Item 7.01 (Regulation FD Disclosure).
SINTX Technologies, Inc. filed an 8-K to announce its quarterly financial results for the period ended March 31, 2025, and provided a general business update via press release.
📋 Key Facts
- Report date: May 15, 2025
- Reporting period: Quarter ended March 31, 2025
- The filing includes results of operations and financial condition under Item 2.02
- A press release was issued as Exhibit 99.1 containing the full details of the update
SINTX Technologies, Inc. entered into new two-year executive employment agreements with CEO Eric K. Olson and CIO Gregg Honigblum, replacing previous agreements.
🚩 Red Flags
- Significant change-in-control 'golden parachute' provisions including a 3x salary/bonus multiplier and 36 months of healthcare coverage.
- The company is obligated to provide 'gross up' payments for excise taxes related to Section 4999 if triggered.
📋 Key Facts
- New employment agreements for CEO Eric K. Olson and CIO Gregg Honigblum were entered into on May 5, 2025.
- Agreements have a two-year term with automatic one-year renewals unless 90 days' notice is given.
- Eric K. Olson to receive an annual base salary of $375,000 and a target cash bonus of 40%.
- Gregg Honigblum to receive an annual base salary of $325,000 and a target cash bonus of 35%.
- Severance provisions include 12 months of base salary if terminated without cause or for good reason.
- Change-in-control provisions include significant lump sum payments (3x base + bonus) and 36 months of health insurance coverage.
SINTX Technologies, Inc. underwent a major board overhaul effective April 3, 2025, involving the appointment of five new directors and the simultaneous resignation of five existing directors. While no disagreements were cited for the departures, the scale of the turnover suggests significant governance restructuring.
🚩 Red Flags
- Mass resignation of five board members simultaneously (including the Audit Committee Chair).
- High turnover in governance roles (Audit, Compensation, and Nominating committees).
📋 Key Facts
- Five new directors appointed: Jay M. Moyes (Audit Chair), Robert D. Mitchell (Nominating/Governance Chair), Mark Anderson (Compensation Chair), Chris Lyons, and Gregg Honigblum.
- Five directors resigned effective April 3, 2025: B. Sonny Bal, David Truetzel, Jeffrey White, Eric Stookey, and Mark Froimson.
- The company explicitly stated that the resignations were not due to any disagreements regarding operations, policies, or practices.
- Jay M. Moyes brings significant financial leadership experience, having served as CFO for several public companies including Myriad Genetics and Sera Prognostics.
SINTX Technologies, Inc. announced a leadership change in its Board of Directors effective March 7, 2025. Eric K. Olson has been appointed as Chairman of the Board, replacing B. Sonny Bal.
📋 Key Facts
- Eric K. Olson appointed as Chairman of the Board on March 7, 2025.
- B. Sonny Bal stepped down from the role of Chairman but remains a member of the Board of Directors.
- Mr. Olson was previously a Director since July 31, 2024.
SINTX Technologies completed a $5.0 million private placement of common stock and warrants on February 25, 2025. The deal includes significant warrant coverage and restrictive covenants regarding future equity issuances.
🚩 Red Flags
- Significant warrant overhang: The issuance of over 1.4 million common warrants at $3.32 represents substantial potential dilution.
- Restrictive covenants: The company is barred from issuing new equity or filing registration statements for a significant period, limiting financial flexibility.
- High cost of capital: Total fees to the placement agent (7.5% on proceeds + 7.5% on warrants + management fee) are substantial.
📋 Key Facts
- Aggregate gross proceeds: $5.0 million (before fees).
- Securities issued: 1,171,189 shares of common stock, 278,098 pre-funded warrants, and 1,449,287 common warrants.
- Common warrant exercise price: $3.32 per share; Pre-funded warrant exercise price: $0.0001 per share.
- H.C. Wainwright & Co. acted as the exclusive placement agent.
- Placement agent fees include a 7.5% cash fee on gross proceeds and warrants, plus an $85,000 expense reimbursement.
- The company is prohibited from issuing new equity or filing registration statements for a period ending 60 days after certain conditions are met (effectively a lock-up/standstill).
- Company agreed not to enter into variable rate transactions for one year after the Effective Date.
Sintx Technologies, Inc. entered into an agreement to sell its wholly owned subsidiary, Technology Assessment and Transfer, Inc. (TA&T), to Tethon Corporation. As part of the transaction, Tethon will assume all outstanding liabilities of TA&T.
🚩 Red Flags
- Liability Transfer: The transaction is structured as a liability assumption, which may suggest the subsidiary carries significant debt or obligations that Sintx seeks to offload.
📋 Key Facts
- Agreement date: February 19, 2025
- Transaction type: Sale of a wholly owned subsidiary (TA&T)
- Buyer: Tethon Corporation
- Consideration: Assumption by Tethon of all outstanding liabilities of TA&T
- The sale involves the transfer of all issued and outstanding shares of TA&T
SINTX Technologies, Inc. held its 2024 annual meeting of stockholders on December 19, 2024. The filing reports the outcomes of several shareholder votes, including director elections and auditor ratification.
🚩 Red Flags
- High number of 'Broker Non-votes' across multiple proposals suggests significant portion of shares are held in street name and did not participate in voting, which can impact quorum/control dynamics.
📋 Key Facts
- Annual meeting held on December 19, 2024.
- Mark Froimson, MD was elected as a Class I director for a three-year term (65,138 votes for vs. 375,417 broker non-votes).
- Shareholders ratified the appointment of Tanner LLC as the independent registered public accounting firm for the year ending December 31, 2024.
- An advisory resolution approving executive compensation was adopted.
- A proposal to amend the 2020 Equity Incentive Plan to increase authorized shares by 333,650 was approved.
SINTX Technologies entered into new or amended change-in-control agreements for its CEO and Chief Strategy Officer. These amendments significantly increase severance obligations in the event of a change in control or subsequent termination.
🚩 Red Flags
- Increased executive severance liabilities (doubling CEO payout) can create significant cash outflows during M&A activity.
- Significant 'golden parachute' triggers and gross-up provisions may incentivize management to favor a change in control that benefits them personally over shareholders.
📋 Key Facts
- Amended Change in Control Agreement for CEO Eric K. Olson increases severance from 1x to 2x his highest annual salary over the preceding three-year period.
- Entered into a new Change of Control Agreement with Chief Strategy Officer Gregg Honigblum, providing for full vesting of options and restricted stock upon change in control.
- Honigblum's agreement includes a severance trigger if terminated without cause or if he resigns for 'good reason' within one year of a change in control, totaling 2x annual salary plus 12 months of health insurance.
- The agreements include 'gross-up' provisions where the company covers excise taxes related to Section 4999 payments.
SINTX Technologies, Inc. announced that its Chief Executive Officer and President, Eric K. Olson, has been appointed to the Company's Board of Directors, effective November 22, 2024.
📋 Key Facts
- Eric K. Olson appointed to the Board of Directors effective November 22, 2024.
- Mr. Olson has served as CEO and President since August 2024.
- No additional compensation will be provided for his board service beyond his existing employment agreement.
- The appointment is not related to any specific arrangements or understandings with third parties.
SINTX Technologies, Inc. has appointed Gregg Honigblum as Chief Strategy Officer, effective November 15, 2024. The appointment includes a six-month initial term with automatic renewals and an executive employment agreement.
📋 Key Facts
- Gregg Honigblum appointed as Chief Strategy Officer effective Nov 15, 2024.
- Honigblum previously served as Managing Director at FNEX Capital, LLC and Westlake Securities.
- Employment Agreement term is six (6) months with automatic six-month renewals.
- Base salary for the initial six-month term is $137,500.
- Severance package includes base salary for a period equal to the longer of three months or the remainder of the initial term if terminated without cause.
SINTX Technologies, Inc. announced that its Board of Directors has authorized a share repurchase program for up to $500,000 of common stock.
🚩 Red Flags
- Relatively small repurchase amount ($500k) which may indicate limited liquidity or a desire to signal confidence without significant capital outlay.
📋 Key Facts
- Board authorization for a share repurchase program on November 18, 2024.
- Maximum repurchase amount is capped at $500,000.
- The company reserves the right to suspend or discontinue the program at its discretion.
- Repurchases will be determined based on capital needs, stock price, and market conditions.
SINTX Technologies entered into an amendment to CEO Eric K. Olson's employment agreement and a new Change of Control Agreement. The filing details extended term provisions and severance/acceleration terms triggered by a change in control or termination without cause.
🚩 Red Flags
- Change of Control Agreement contains significant acceleration and severance triggers which can be seen as defensive or incentivizing management during M&A activity.
📋 Key Facts
- CEO Eric K. Olson's employment term was extended from 6 months to 12 months, with automatic 6-month renewals.
- A Change of Control Agreement was executed for Mr. Olson.
- Change in control triggers full vesting of all outstanding options, restricted stock, and other rights held by the executive.
- Severance includes a lump sum payment equal to one times his highest annual salary (including bonuses) if terminated without cause or if he resigns for 'good reason' within one year of a change in control.
- The agreement includes a 'gross up' provision for excise taxes under Section 4999 related to change in control payments.
SINTX Technologies, Inc. announced a new Executive Employment Agreement with CEO and President Eric K. Olson on September 20, 2024. The agreement establishes a six-month term with automatic renewals and defines compensation including salary, bonuses, and severance terms.
🚩 Red Flags
- Short-term contract structure (6-month increments) may indicate management instability or a transitional leadership phase.
📋 Key Facts
- CEO/President Eric K. Olson entered into an Executive Employment Agreement effective September 20, 2024.
- Agreement term is six (6) months with automatic six-month renewals unless 30 days' notice is provided.
- Annual base salary set at $350,000.
- A $25,000 cash bonus was triggered upon execution of the agreement.
- Severance terms include base salary for the longer of three months or the remainder of the initial term if terminated without cause/for good reason.
SINTX Technologies, Inc. announced a leadership transition effective August 1, 2024, appointing Eric K. Olson as the new CEO and President. The previous CEO, B. Sonny Bal, has retired from his executive role to serve as Chairman of the Board.
🚩 Red Flags
- CEO transition can often signal internal strategic shifts or challenges in the micro-cap space.
📋 Key Facts
- Eric K. Olson appointed as Chief Executive Officer and President effective August 1, 2024.
- B. Sonny Bal retired as CEO/President and transitioned to Chairman of the Board.
- Olson previously served as CEO of SINTX (formerly Amedica Corporation) from February 2012 to September 2014.
- Olson's background includes leadership roles at Foresite Innovations, Predictive Biotech, Skeletal Kinetics, and Smith & Nephew.
Sintx Technologies is re-activating its At-The-Market (ATM) equity offering program with Maxim Group LLC. The company intends to register the sale of common stock up to an aggregate price of $3,115,475 to fund working capital and general corporate purposes.
🚩 Red Flags
- Potential dilution of existing shareholders through continuous equity issuance.
- The company previously suspended sales under this ATM agreement in March 2024, suggesting a prior need to halt capital raising or manage share price impact.
📋 Key Facts
- Re-activating ATM Agreement originally entered into on February 25, 2021.
- Aggregate offering amount: $3,115,475.
- Sales agent: Maxim Group LLC.
- Shares to be sold under the existing Form S-3 shelf registration (No. 333-274951).
- Proceeds intended for working capital and general corporate purposes.
SINTX Technologies, Inc. announced that it has successfully regained compliance with the Nasdaq Bid Price Requirement as of June 12, 2024.
🚩 Red Flags
- Previous non-compliance with Nasdaq Bid Price Requirement indicates historical volatility or low share price.
📋 Key Facts
- Company regained compliance with the Nasdaq Bid Price Requirement on June 12, 2024.
- The announcement was made via a press release issued on June 12, 2024.
- Compliance status is reported under Item 8.01 (Other Events).
SINTX Technologies, Inc. has announced a 1-for-200 reverse stock split to be effective on May 28, 2024. This follows stockholder approval from a special meeting held on May 14, 2024.
🚩 Red Flags
- Reverse stock split (often used to maintain NASDAQ compliance or combat low share prices)
- Significant dilution/consolidation of shares
📋 Key Facts
- Reverse stock split ratio: 1-for-200
- Effective Date/Time: 12:01 a.m. ET on May 28, 2024
- New CUSIP number for Common Stock: 829392703
- Fractional shares will be rounded up to the nearest whole share
- Proportionate adjustments will apply to warrants, preferred stock, and equity awards
SINTX Technologies, Inc. held a Special Meeting of Stockholders on May 14, 2024, where shareholders approved a proposal to implement a reverse stock split. The Board is authorized to execute a split at a ratio between 1-for-100 and 1-for-300 within the next twelve months.
🚩 Red Flags
- Approval of a significant reverse stock split (up to 1-for-300) is often used to combat delisting notices or improve share price, signaling potential liquidity or valuation distress.
- The wide range of the ratio (1:100 to 1:300) suggests high uncertainty regarding the required scale of the consolidation.
📋 Key Facts
- Special Meeting held on May 14, 2024.
- Proposal 1 (Reverse Stock Split) approved with 20,689,236 votes in favor and 3,294,971 against.
- The reverse split ratio can be anywhere from 1-for-100 to 1-for-300 at the Board's discretion.
- Quorum was met with 24,134,268 shares represented (out of 51,080,139 total outstanding).
- The Board has authority to implement the split within a 12-month window without further stockholder approval.
SINTX Technologies announced that CEO B. Sonny Bal, MD, intends to retire from his role as President and CEO once a successor is named. Dr. Bal will transition to the role of Chairman of the Board upon his retirement.
🚩 Red Flags
- Leadership transition creates temporary uncertainty regarding executive continuity until a successor is named.
- Cash outflow associated with the separation agreement (3 months salary + COBRA).
📋 Key Facts
- Effective date: Upon naming a replacement President and CEO.
- Dr. Bal will continue to serve on the board as Chairman.
- Separation Agreement includes a lump sum payment equal to three months of salary.
- Company will pay Dr. Bal's COBRA premiums for three months if elected.
- The Board is conducting a search for both internal and external candidates.
SINTX Technologies has received a formal notice from Nasdaq to delist its common stock after failing to maintain the minimum bid price requirement. The company's stock closed at $0.10 or less for ten consecutive trading days as of April 5, 2024.
🚩 Red Flags
- Delisting notice from Nasdaq
- Extreme share price depreciation (trading at $0.10 or less)
- Failure to regain compliance within the initial 180-day grace period
📋 Key Facts
- Nasdaq determined the Company is in violation of Listing Rule 5810(c)(3)(A)(iii) due to a closing bid price of $0.10 or less for ten consecutive trading days.
- The company was previously notified on October 20, 2023, regarding non-compliance with the $1.00 minimum bid price requirement.
- The delisting notice provides until April 15, 2024, to request a hearing before an independent Hearings Panel.
- A requested hearing would stay the delisting action and could potentially grant an extension through October 7, 2024.
SINTX Technologies entered into a stock purchase agreement to issue 71,600,000 shares of common stock at a price of $0.021 per share. The offering aims to raise approximately $1.5 million in gross proceeds to fund company operations.
🚩 Red Flags
- Extremely low share price ($0.021) indicates a highly distressed or micro-cap valuation.
- Massive dilution: Issuing 71.6 million shares at such a low price significantly dilutes existing shareholders.
- Small capital raise ($1.5M gross) relative to the massive number of shares issued suggests urgent need for liquidity.
📋 Key Facts
- Offering size: 71,600,000 shares of common stock.
- Offering price: $0.021 per share.
- Expected aggregate proceeds: Approximately $1.5 million (before fees).
- Placement Agent: Maxim Group LLC.
- Placement Agent fee: 8.0% cash fee plus reimbursement of expenses/legal fees up to $65,000.
- Closing date: Expected April 5, 2024.
SINTX Technologies announced a highly dilutive common stock offering of 28.4 million shares at $0.047 per share to raise approximately $1.3 million in gross proceeds.
🚩 Red Flags
- Extreme dilution: The offering of 28.4 million shares at a very low price ($0.047) suggests significant dilution for existing shareholders.
- Low share price: Pricing at $0.047 is characteristic of distressed micro-cap companies and may trigger NASDAQ minimum bid price requirements (delisting risk).
- High cost of capital: The company is paying an 8% fee plus substantial expense reimbursements to the placement agent for a relatively small amount of gross proceeds.
📋 Key Facts
- Offering size: 28,400,000 shares of common stock.
- Offering price: $0.047 per share.
- Expected aggregate gross proceeds: ~$1.3 million.
- Placement Agent: Maxim Group LLC (8.0% cash fee + up to $90,000 in expenses/legal fees).
- Closing date expected: March 26, 2024.
SINTX Technologies announced that its insurance carrier has approved coverage for a loss involving an overheated sintering furnace at SINTX Armor in October 2023. The company plans to replace the equipment and expects it to be operational by Q4 2024, while temporarily outsourcing production.
🚩 Red Flags
- Operational disruption: The company is forced to outsource core manufacturing processes due to equipment failure.
- Revenue/Margin risk: Outsourcing and delayed equipment uptime (Q4 2024) may impact short-term margins and delivery timelines.
📋 Key Facts
- Insurance carrier confirmed coverage for a claim related to an overheated sintering furnace at SINTX Armor (event occurred October 2023).
- The company will replace the damaged furnace.
- Expected timeline for repaired/new furnace to be operational: 4th quarter 2024.
- Management is currently outsourcing the sintering process to third parties to mitigate production gaps.
SINTX Technologies entered into a securities purchase agreement to issue 16 million units, consisting of common stock and pre-funded warrants, for approximately $4 million in gross proceeds. The offering includes significant warrant coverage (Class E and F) that will result in substantial potential dilution.
🚩 Red Flags
- Extreme dilution risk: The issuance of 16 million units alongside Class E/F warrants (totaling potentially 32 million additional shares) represents massive dilution for existing shareholders.
- Low-cost exercise prices ($0.0001 and $0.25) suggest a 'death spiral' or highly dilutive financing structure common in distressed micro-caps.
- Significant warrant overhang: The combination of pre-funded warrants, Class E/F warrants, and placement agent warrants creates massive downward pressure on share price upon exercise.
📋 Key Facts
- Aggregate expected gross proceeds: ~$4 million before fees.
- Offering consists of 16,000,000 units: 3,400,000 Common Units (at $0.25/unit) and 12,600,000 Pre-Funded Warrant Units (at $0.2499/unit).
- Includes Class E warrants to purchase 16,000,000 shares at $0.25; expires in 5 years.
- Includes Class F warrants to purchase 16,000,000 shares at $0.25; expires in 18 months.
- Pre-funded warrants are exercisable at a nominal price of $0.0001 per share.
- Maxim Group LLC acting as placement agent with a 7.0% cash fee plus reimbursement of expenses up to $100,000 and 640,000 stock purchase warrants.
SINTX Technologies has entered into a five-year Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Army Research Laboratory. The collaboration focuses on binder jetting technology and densification methods for 3D printed green bodies.
📋 Key Facts
- Agreement type: Cooperative Research and Development Agreement (CRADA)
- Counterparty: U.S. Army Combat Capabilities Development Command Army Research Laboratory
- Research focus: Binder jetting and densification of green bodies in 3D printing processes
- Duration: Five years
- Funding structure: Each party agrees to fund its own research costs
SINTX Technologies, Inc. issued an 8-K to announce preliminary revenue results for the fourth quarter and full fiscal year ended December 31, 2023.
📋 Key Facts
- Report date: January 23, 2024
- Content: Preliminary revenue results for Q4 and FY 2023
- The information provided under Item 2.02 is not deemed 'filed' for purposes of Section 18 liability.
Sintx Technologies, Inc. issued an 8-K to announce the award of certain patents via a press release. The filing contains no material financial changes or structural shifts.
📋 Key Facts
- Company announced the award of certain patents on January 4, 2024.
- The announcement was made via a press release attached as Exhibit 99.1.
- No specific patent numbers or technical details were disclosed in the 8-K text itself.